978 related articles for article (PubMed ID: 17258590)
1. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience.
Saouti N; Morshuis WJ; Heijmen RH; Snijder RJ
Eur J Cardiothorac Surg; 2009 Jun; 35(6):947-52; discussion 952. PubMed ID: 19272789
[TBL] [Abstract][Full Text] [Related]
3. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Matsuda H; Ogino H; Minatoya K; Sasaki H; Nakanishi N; Kyotani S; Kobayashi J; Yagihara T; Kitamura S
Ann Thorac Surg; 2006 Oct; 82(4):1338-43; discussion 1343. PubMed ID: 16996930
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension: a pilot study.
Skoro-Sajer N; Hack N; Sadushi-Koliçi R; Bonderman D; Jakowitsch J; Klepetko W; Hoda MA; Kneussl MP; Fedullo P; Lang IM
Circulation; 2009 Jan; 119(2):298-305. PubMed ID: 19118254
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal follow-up of six-minute walk distance after pulmonary endarterectomy.
van der Plas MN; Surie S; Reesink HJ; van Steenwijk RP; Kloek JJ; Bresser P
Ann Thorac Surg; 2011 Apr; 91(4):1094-9. PubMed ID: 21440129
[TBL] [Abstract][Full Text] [Related]
6. [Chronic thromboembolic pulmonary hypertension: surgical treatment with thromboendarterectomy].
Blázquez JA; Escribano P; Pérez E; López MJ; Gómez MA; Cortina JM
Arch Bronconeumol; 2009 Oct; 45(10):496-501. PubMed ID: 19656605
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: preliminary exploration in China.
Gu S; Liu Y; Su PX; Zhai ZG; Yang YH; Wang C
Chin Med J (Engl); 2010 Apr; 123(8):979-83. PubMed ID: 20497700
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.
Leuchte HH; Holzapfel M; Baumgartner RA; Ding I; Neurohr C; Vogeser M; Kolbe T; Schwaiblmair M; Behr J
J Am Coll Cardiol; 2004 Mar; 43(5):764-70. PubMed ID: 14998614
[TBL] [Abstract][Full Text] [Related]
11. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
[TBL] [Abstract][Full Text] [Related]
12. Functional and haemodynamic outcome 1 year after pulmonary thromboendarterectomy.
Freed DH; Thomson BM; Tsui SS; Dunning JJ; Sheares KK; Pepke-Zaba J; Jenkins DP
Eur J Cardiothorac Surg; 2008 Sep; 34(3):525-9; discussion 529-30. PubMed ID: 18501623
[TBL] [Abstract][Full Text] [Related]
13. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
14. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
15. Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension.
Ogino H; Ando M; Matsuda H; Minatoya K; Sasaki H; Nakanishi N; Kyotani S; Imanaka H; Kitamura S
Ann Thorac Surg; 2006 Aug; 82(2):630-6. PubMed ID: 16863777
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary endarterectomy improves dyspnea by the relief of dead space ventilation.
van der Plas MN; Reesink HJ; Roos CM; van Steenwijk RP; Kloek JJ; Bresser P
Ann Thorac Surg; 2010 Feb; 89(2):347-52. PubMed ID: 20103296
[TBL] [Abstract][Full Text] [Related]
17. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension.
Freed DH; Thomson BM; Berman M; Tsui SS; Dunning J; Sheares KK; Pepke-Zaba J; Jenkins DP
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):383-7. PubMed ID: 20471039
[TBL] [Abstract][Full Text] [Related]
18. [Chronic thromboembolic pulmonary hypertension: can successful thrombendarterectomy normalize exercise capacity and gas exchange?].
Ben-Dov I; Kogan A; Preisman S; Rimon U; Segev A; Schafers JH
Harefuah; 2012 Feb; 151(2):74-8, 129, 128. PubMed ID: 22741205
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after pulmonary endarterectomy.
Corsico AG; D'Armini AM; Cerveri I; Klersy C; Ansaldo E; Niniano R; Gatto E; Monterosso C; Morsolini M; Nicolardi S; Tramontin C; Pozzi E; Viganò M
Am J Respir Crit Care Med; 2008 Aug; 178(4):419-24. PubMed ID: 18556630
[TBL] [Abstract][Full Text] [Related]
20. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
